Experience in surgical treatment for active endocarditis at Ho Chi Minh Institute

Van Hung Dung , Bui Minh Trang

Main Article Content

Abstract

Background: Surgical treatment for active infective endocarditis are always complex with many severe complications. Indications for surgery and the timing of surgery are still debated. 


Patient and Method: retrospected all infective endocarditis patients who were operated on at HCM Heart Institute from 1995 to 2020 and focused on the group of active infective endocarditis.


Results:


In total, there have 568 infective endocarditis patients were operated and among that active infective endocarditis were 138 patients (24.3%). In this group, according to pathology were as follows:15 on the native valve, 30 on the congenital defect, 56 on previous valvular heart disease, 2 post pace marker, and 35 on post valvular surgery. In most cases, pathogens of endocarditis were Streptococci spp (42%) and Staphyloccocus aureus (29,7%). Per operation, 100% of cases find out vegetations and 42 cases have an annular abscess.


The surgical procedure was as follows: vegetations ablation and radical repair of congenital defect:30; valve repair: 24; valve replacement: 77; electrodes ablation: 2, and  Bentall’s procedure: 5. Operative mortality was 11 cases (8%):  3 cerebral hemorrhages, 3 multi-organ failure, and 4 low cardiac output. The median time of follow-up was 11.2 years. Redo in the 1st 3month and after 1 year caused by desinsertion ring or valve prosthesis were 12 cases and 4 cases, respectively.  Late death after 1 year was 6 (4 irreversible HF, 1 cerebral hemorrhage, and 1 sudden death). The rest cases have been stable.


Conclusion


Surgical treatment for active infective endocarditis has good results although the outcome is complex and the duration of hospital stay is very long. Early surgery for active infective endocarditis could solve radical infective lesions with a mortality rate acceptable.

Article Details

References

1. LM. Baddour, WR. Wilson, AS. Bayer, VG. Fowler, IM. Tleyjeh, M J. Rybak, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. Circulation. 2015;132:00-00. DOI: 10.1161/ CIR.000000000000296.
2. JS. Li, DJ. Sexton, N Mick, R Nettles, VG. Fowler, T Ryan, T Bashore, and GR. Corey. Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis. Clinical Infectious Diseases 2000;30:633–8
3. JG. Byrne, K. Rezai, JA. Sanchez, RA. Bernstein, E. Okum, M. Leacche, et al. Surgical Management of Endocarditis: The Society of Thoracic Surgeons Clinical Practice Guideline. Ann Thorac Surg 2011;91:2012–9.
4. G. Habib, P. Lancellotti, MJ. Antunes, MG. Bongiorni, JP Casalta, F. Del Zotti, et al. 2015 ESC Guidelines for the management of infective endocarditis. European Heart Journal doi:10.1093/eurheartj/ehv319.
5. Gösta B. Pettersson, Syed T. Hussain.Current AATS guidelines on surgical treatment of infective endocarditis Ann Cardiothorac Surg 2019;8(6):630-644.
6. F Caes, T Bové, YV Belleghem, G Vandenplas, GV Nooten and K. François.Reappraisal of a single-center policy on the contemporary surgical management of active infective endocarditis. Interac CardioVasc Thorac Surg 2017;18: 169–176.
7. P Chen, C Chang, Y Chuang, I Chen and T Lin. Modified commando procedure in complicated infective endocarditis ─ a case series. J Cardiothorac Surg 2021; 16:79
8. TJ Cahill, BD Prendergast. Infective Endocarditis. Lancet 2016,V.287:882-893.
9. S Funakoshi, S Kaji, A Yamamuro, T Tani, M Kinoshita, Y Okada, and Y Furukawa. Impact of early surgery in the active phase on long-term outcomes in left-sided native valve infective endocarditis. J Thorac Cardiovasc Surg 2011;142:836-4.
10. DH. Kang, YJ Kim, SH Kim, BJ Sun, DH Kim, SC Yun, JM Song, et al. Early Surgery versus Conventional Treatment for Infective Endocarditis. N Engl J Med 2012;366:2466-73.
11. NA. Morris, M. Matiello, JL. Lyons, and MA. Samuels. Neurologic Complications in Infective Endocarditis: Identification, Management, and Impact on Cardiac Surgery. The Neurohospitalist 2014, Vol. 4(4) 213-222
12. M Musci, M Hubler, A Amiri, J Stein, S Kosky, R Meyer, Y Weng, R Hetzer. Surgical treatment for active infective prosthetic valve endocarditis: a 22-year single-center experience. Euro J Cardio-thorac Surg 2010;38: 528—538
13. M. Rossi, A. Gallo, R. Joseph De Silva and R. Sayeed. What is the optimal timing for surgery in infective endocarditis with cerebrovascular complications? Interac CardioVasc Thorac Surg 2011;0: 1–9 doi:10.1093/icvts/ivr010
14. D Yoshiokaa, K Todaa, T Sakaguchia, S Okazakib, T Yamauchia, S Miyagawaa, et al. OSCAR study group. Valve surgery in active endocarditis patients complicated by intracranial hemorrhage: the influence of the timing of surgery on neurological outcomes. Eur J Cardio-Thorac Surg 2014;45: 1082–1088.
15. F. Thuny, JY. Gaubert, A. Jacquier, L. Tessonnier, S. Cammilleri, D. Raoult, G. Habib. Imaging investigations in infective endocarditis: current approach and perspectives. Archives of Cardiovascular disease 2013;106:52-62.
16. P.Y.K. Pang, YK. Sin, CH.Lim, TE.Tan, SL.Lim, VT.T. Chao and YL.Chua. Surgical management of infective endocarditis: an analysis of early and late outcomes. Euro J Cardio-Thorac Surg 2015;47: 826–832
17. ASV.Shah, DA. McAllister, P Gallacher, F Astengo, JA Rodríguez Pérez, J Hall, M et al. Incidence, Microbiology, and Outcomes in Patients Hospitalized with Infective Endocarditis. Circulation 2020;141:2067–2077. doi: 10.1161/circulationaha.119.044913
18. M Luehr, N Bauernschmitt, S Peters, Y Li, O Heyn, A Dashkevich, et al. Incidence and surgical outcomes of patients with native and prosthetic aortic valve endocarditis. Ann Thorac Surg 2019; 110(1): 93-101.